Losing significant weight improves health markers, reduces risk of serious diseases, and often decreases spending on other medications or health conditions related to excess weight
In January, drugmaker Novo Nordisk released an oral version of Wegovy, its semaglutide medication for weight loss, taken once daily and available by prescription
The management of side effects is not just about dealing with discomfort but also ensuring that the treatment continues to be effective and sustainable in the long term
In a nitroglycerin-induced chronic migraine (CM) mouse model, GLP-1R expression was markedly increased and colocalized with microglia and astrocytes in the trigeminal nucleus caudalis (TNC) [94]
The meteoric rise of a new class of weight loss drugs over the past two years, known as GLP-1s, has seen a new name take the title of Europes most valuable company, helped a country dodge a recession and hit grocery sales in the US